Clinical Trial Update: Trial Evaluating Paliperidone Extended-Release (ER) Tablets Versus Placebo on Sleep in Schizophrenia Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating paliperidone extended-release tablets versus placebo on sleep in schizophrenia patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia
• Schizophrenia

Drugs mentioned

• INVEGA (PALIPERIDONE)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Schizophrenia, Insomnia | Phase 2 | Status: COMPLETED